World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00715195
Date of registration: 11/07/2008
Prospective Registration: No
Primary sponsor: Assistance Publique - Hôpitaux de Paris
Public title: Improving Quality of Life of Fibromyalgia Patients Aquavip
Scientific title: Evaluation of Improving Quality of Life of Fibromyalgia Patients Treated With a Plurifocal Program : a Controlled Study With 12 Months Monitoring.
Date of first enrolment: September 2007
Target sample size: 115
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00715195
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Guy COICHARD, MD Ph
Address: 
Telephone:
Email:
Affiliation:  Assistance Publique - Hôpitaux de Paris
Key inclusion & exclusion criteria

Inclusion Criteria:

- Fibromyalgia Patients according to the criteria of the American College of
Rheumatology defined by:

- diffuse pain evolving for over three months

- pain on palpation of at least 11 of the 18 sites listed

- age between 18 and 65

- FIQ Score higher than 35/100 at inclusion

- Ability to respond to questionnaires

- monitoring possibility for at least a year

- Affiliation to the French Health System (social security)

Exclusion Criteria:

- Association with chronic pain from other sources which can interfere with
fibromyalgia assessment

- Inability to follow the full educational program

- previous participation in an educational program of same nature

- psychological disorder (personality disorder or behaviour, schizophrenia), preventing
participation in the program group



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Fibromyalgia
Intervention(s)
Behavioral: Plurifocal educational program
Primary Outcome(s)
Score of the Fibromyalgia Impact Questionnaire, at one month and twelve months after program end [Time Frame: one month and twelve months after program end]
Secondary Outcome(s)
Pain Numeric scale,Number of tender points, Sleep quality numeric scale,Pain Impact Questionnaire ANAES,STAI-Y anxiety questionnaire,Beck Depression Index II,Coping Strategy Questionnaire,Multidimensional self-assessment(SF36, PSOCQ) [Time Frame: one , six and twelve months after program end]
Secondary ID(s)
P051029
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Fondation de France
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history